These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

633 related items for PubMed ID: 25634851

  • 21. New medications for obesity management: changing the landscape of obesity treatment.
    Boulghassoul-Pietrzykowska N, Franceschelli J, Still C.
    Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):407-11. PubMed ID: 23974768
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Obesity Epidemic: Pharmaceutical Weight Loss.
    Curry SA.
    R I Med J (2013); 2017 Mar 01; 100(2):18-20. PubMed ID: 28246654
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pharmacotherapy for obesity in individuals with type 2 diabetes.
    Chukir T, Shukla AP, Saunders KH, Aronne LJ.
    Expert Opin Pharmacother; 2018 Feb 01; 19(3):223-231. PubMed ID: 29376439
    [Abstract] [Full Text] [Related]

  • 27. Pharmacological treatment of obesity in Europe: waiting for the arrival of the white blackbird.
    Rubio MA.
    Endocrinol Nutr; 2014 Dec 01; 61(10):501-4. PubMed ID: 25434595
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Efficacy comparison of medications approved for chronic weight management.
    Kumar RB, Aronne LJ.
    Obesity (Silver Spring); 2015 Apr 01; 23 Suppl 1():S4-7. PubMed ID: 25900871
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Practical Use of Pharmacotherapy for Obesity.
    Igel LI, Kumar RB, Saunders KH, Aronne LJ.
    Gastroenterology; 2017 May 01; 152(7):1765-1779. PubMed ID: 28192104
    [Abstract] [Full Text] [Related]

  • 33. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
    Bays H.
    Expert Rev Cardiovasc Ther; 2010 Dec 01; 8(12):1777-801. PubMed ID: 20707765
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pharmacotherapy for the management of obesity.
    Patel D.
    Metabolism; 2015 Nov 01; 64(11):1376-85. PubMed ID: 26342499
    [Abstract] [Full Text] [Related]

  • 36. [Cutting-edge of medicine; the prospects of novel anti-obesity drugs].
    Ueno H, Nakazato M.
    Nihon Naika Gakkai Zasshi; 2014 Mar 10; 103(3):753-9. PubMed ID: 24796150
    [No Abstract] [Full Text] [Related]

  • 37. Safety and tolerability of medications approved for chronic weight management.
    Fujioka K.
    Obesity (Silver Spring); 2015 Apr 10; 23 Suppl 1():S7-11. PubMed ID: 25900872
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. New pharmacological approaches for obesity management.
    Rueda-Clausen CF, Padwal RS, Sharma AM.
    Nat Rev Endocrinol; 2013 Aug 10; 9(8):467-78. PubMed ID: 23752772
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.